세계의 경경정맥 간내문맥 션트 시장 : 제품 유형, 수술 유형, 재료 유형, 용도, 최종 사용자별 예측(2025-2030년)

The Transjugular Intrahepatic Portosystemic Shunt Market was valued at USD 102.55 million in 2024 and is projected to grow to USD 106.78 million in 2025, with a CAGR of 4.27%, reaching USD 131.81 million by 2030.

The transjugular intrahepatic portosystemic shunt (TIPS) represents a critical intervention in the management of portal hypertension and its ensuing complications. This comprehensive executive summary delves into the complex dynamics of the TIPS market, detailing the technological innovations, evolving procedural techniques, and strategic market segmentation that drive growth and transform patient care outcomes.

In today's era of rapid medical advancement, TIPS procedures have emerged as a pivotal treatment option particularly aimed at alleviating complications associated with liver cirrhosis, portal hypertension, and conditions like Budd-Chiari Syndrome. Clinical successes combined with heightened emphasis on patient safety and post-procedure care have bolstered interest across a range of end-users from hospitals to specialty clinics. As regulatory landscapes continue to evolve and novel medical devices enhance the intervention's efficacy, stakeholders find themselves navigating not only clinical trials and product innovation but formidable market challenges tied to competitive dynamics and cost-constraints.

This summary provides an in-depth look at the transformative shifts within the TIPS market, rigorous segmentation approaches that illuminate key industry trends, and strategic recommendations designed for industry leaders targeting sustained market success. The analysis supported by qualitative and quantitative insights sets a foundation that underpins strategic decision-making in a rapidly evolving healthcare paradigm.

Transformative Shifts in the TIPS Market Landscape

Over the past decade, the TIPS landscape has undergone transformative shifts that have redefined the market's structure and value proposition. Several key factors are driving this evolution.

One significant shift is the accelerated pace of technological innovation. Medical devices specifically designed for TIPS now boast advanced features, greater precision in shunt placement, and improved patient outcomes. This evolution is complemented by new research studies that validate clinical efficacy, driving confidence among both practitioners and patients. The development of accessory devices-ranging from balloon expanders to catheters and guiding wires-has modernized procedural techniques, enabling smoother operations and reduced operative risks.

Concurrently, these innovations have been met with rigorous reinvestments in research and development driven by leading manufacturers and research institutes alike. Regulatory bodies are also adapting their guidelines to support the introduction of innovative therapies while ensuring safety and compliance. These forward-thinking policies, coupled with market liberalization in many regions, have provided ample opportunity for stakeholders to explore new clinical applications and process improvements.

Another transformative force is the merging of clinical data with commercially driven insights. Institutions are increasingly leveraging real-world evidence to refine product development and improve patient protocols, catalyzing a shift from traditional treatment modalities to more integrated, technology-enhanced approaches. This blend of data-driven insights and innovative product offerings has reshaped the competitive landscape, inviting collaboration and strategic alliances among device manufacturers, healthcare providers, and research agencies.

In essence, the market is experiencing a notable shift not only from conventional procedural methods to cutting-edge technological integration but also towards a more patient-centric approach. Industry players who effectively harness these dynamics are well positioned to drive future market growth while enhancing clinical outcomes for a diverse patient demographic.

Key Segmentation Insights in the TIPS Market

The segmentation analysis of the TIPS market provides a multi-layered view that assists industry stakeholders in identifying growth opportunities and understanding market diversification. In reviewing product type, the market is predominantly divided between accessory devices and stents. The segment for accessory devices is meticulously examined to include components such as balloon expanders, catheters, and guiding wires, each of which plays a vital role in improving procedural accuracy and patient safety. In contrast, the stent category is further nuanced into bare metal stents, drug-eluting stents, and sectional stents, highlighting the evolution of materials and design tailored to specific clinical scenarios.

A separate segmentation perspective is offered by procedure type, where both elective and emergency shunts are scrutinized. Recognizing that emergency shunts often require rapid deployment without compromising efficacy, there has been an emphasis on streamlining protocols and ensuring device reliability under time-sensitive conditions. This is balanced with elective shunts where the planning and computational methodologies are more extensively developed to tailor interventions to individual patient needs.

Material type segmentation also provides intriguing insights into the market's progression, with a clear division between metallic stents, known for their durability and long-term performance, and polymer-based solutions that offer flexibility and cost-effectiveness. Each material type demonstrates differing clinical benefits and risk profiles, which in turn influence market adoption and pricing strategies.

Moreover, analysing the application segment reveals that the market is designed to address a wide spectrum of liver-related health conditions. Conditions such as Budd-Chiari Syndrome, Hepatitis C, liver cirrhosis, and portal hypertension not only reflect the therapeutic versatility of TIPS procedures but also underscore the challenges in managing these complex diseases. Finally, evaluation based on end-user segments indicates a diverse range that includes ambulatory surgical centers, hospitals, research institutes, and specialty clinics. The distribution underscores the widespread acceptance and utility of TIPS procedures across various healthcare infrastructures, further bolstering market demand and encouraging innovation across device classes.

Based on Product Type, market is studied across Accessory Devices and Stents. The Accessory Devices is further studied across Balloon Expanders, Catheters, and Guiding Wires. The Stents is further studied across Bare Metal Stents, Drug-Eluting Stents, and Sectional Stents.

Based on Procedure Type, market is studied across Elective Shunts and Emergency Shunts.

Based on Material Type, market is studied across Metallic Stents and Polymers.

Based on Application, market is studied across Budd-Chiari Syndrome, Hepatitis C, Liver Cirrhosis, and Portal Hypertension.

Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, Research Institutes, and Specialty Clinics.

Regional Insights and Market Penetration Trends

An examination of regional trends reveals a multifaceted market with distinct growth patterns across geographies. The Americas have exhibited robust market growth driven by high healthcare spending, advanced clinical infrastructure, and strong research investments. There is significant adoption of TIPS procedures in this region, supported by a well-coordinated network of tertiary care centers and a proactive regulatory environment that facilitates innovation.

In the Europe, Middle East & Africa region, market dynamics are influenced by a combination of mature healthcare frameworks in developed European countries and evolving infrastructure in various MEA nations. Here, incremental investments in healthcare technology have enhanced the operational efficiency of TIPS procedures, while cross-border collaborations and knowledge-sharing initiatives are fostering greater clinical confidence.

The Asia-Pacific region is emerging as a critical growth driver for the TIPS market. Rapid urbanization, improving healthcare facilities, and increased access to cutting-edge medical interventions are fueling demand in this region. Local and international manufacturers are keenly tuning into the region's vast potential by customizing their product offerings to suit the demographic and clinical idiosyncrasies particular to diverse markets in Asia-Pacific. Collectively, these regional variations offer valuable insights that can assist market participants in tailoring their approaches to meet localized needs and drive sustained market penetration.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Strategic Insights into Leading Industry Players

A competitive analysis of the TIPS market underscores the presence of major players with significant influence over technological and clinical advancements in the field. Companies such as AngioDynamics Inc. and Argon Medical Devices, Inc. are at the forefront of driving product innovations, particularly in designing state-of-the-art accessory devices and advanced stent solutions. Their focus on developing balloon expanders, catheters, and guiding wires continues to set industry benchmarks for procedural efficiency and safety.

Becton, Dickinson and Company and Boston Scientific Corporation have harnessed their extensive research capabilities to introduce breakthrough technologies that enhance device performance while optimizing cost efficiency. The rigorous R&D efforts spearheaded by leaders like Cook Group Incorporated and Medtronic have been pivotal in ensuring that clinical outcomes are both safe and reproducible.

Merit Medical Systems, Inc. along with Siemens Healthcare Limited, have contributed to streamlining manufacturing processes, further refining the precision of TIPS-related devices. Sirtex Medical Inc., Terumo Medical Corporation, and W. L. Gore & Associates, Inc. have also carved niche yet decisive market segments by focusing on specific device innovations tailored to meet varied clinical requirements.

The strategic interplay among these top companies is fostering a competitive yet collaborative environment in the market. Their continuous improvements in device design, coupled with advancements in procedural technology, create immense value for healthcare providers. This, in turn, ensures that patient outcomes remain at the core of innovation, thereby delivering a blend of operational excellence and clinical safety that sustains industry growth over time.

The report delves into recent significant developments in the Transjugular Intrahepatic Portosystemic Shunt Market, highlighting leading vendors and their innovative profiles. These include AngioDynamics Inc., Argon Medical Devices, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Cook Group Incorporated, Medtronic, Merit Medical Systems, Inc., Siemens Healthcare Limited, Sirtex Medical Inc., Terumo Medical Corporation, and W. L. Gore & Associates, Inc.. Actionable Recommendations for Growing Market Leaders

Industry leaders looking to secure a competitive edge in the TIPS market should embrace a multi-pronged strategy that promotes innovation, operational efficiency, and market adaptability. A primary recommendation is to advance research and development initiatives not only in terms of hardware-such as improving the design of accessory devices and stents-but also in integrating digital health technologies that allow for real-time data monitoring and outcomes analysis. Collaboration between surgeons, researchers, and technologists can pave the way for developing devices that are adaptable to both elective and emergency procedural demands.

Another essential strategy involves expanding the geographical footprint by tailoring device solutions to the unique needs of various regions. Understanding local regulatory frameworks and healthcare practices is key; thus, an investment in regional market research can unveil opportunities to customize products and streamline distribution channels. Leaders are encouraged to foster strong alliances with local hospitals, research institutes, and specialty clinics to build a resilient network that is capable of addressing both acute and chronic conditions linked to portal hypertension, liver cirrhosis, and other liver-associated diseases.

On the operational front, implementing best practices in manufacturing and quality assurance can significantly reduce production costs while enhancing reliability. By leveraging automation and adopting standardized protocols across multiple facilities, companies can achieve economies of scale and ensure consistent device quality irrespective of the production location.

Lastly, a robust post-market surveillance system is crucial in maintaining safety and efficacy benchmarks. Industry players should invest in systems that facilitate rapid feedback from healthcare providers, enabling quick adjustments to device design and procedural protocols. This proactive approach not only improves patient outcomes but enhances market reputation, supporting long-term brand loyalty and trust among medical professionals.

Collectively, these actionable strategies serve as a roadmap for leaders intent on not just maintaining relevance but also in spearheading innovation and operational excellence in the TIPS market.

Conclusion: Steering the Future of TIPS Interventions

In conclusion, the market for transjugular intrahepatic portosystemic shunt procedures is marked by dynamic changes that are rapidly redefining clinical practices and market structures. This comprehensive analysis has highlighted the significance of robust segmentation strategies, regional market trends, and competitive insights that together provide a holistic view of the industry landscape.

Innovation remains the cornerstone of progress in the TIPS market, with technological breakthroughs in accessory devices, stent designs, and procedural protocols playing a pivotal role in enhancing patient care. The evolution of both elective and emergency shunt procedures underscores a shift as stakeholders are increasingly focusing on precision, safety, and adaptability.

Strategic collaborations among industry leaders and continuous investments in R&D signal a future where high-performance devices become the norm. The dynamic interplay of market segmentation factors-from product types and material compositions to procedural approaches and end-user engagements-offers a detailed map for navigating the challenges and opportunities in this evolving space.

The insights presented herein empower decision-makers with the necessary tools to forge ahead in a competitive environment. By embracing innovation, improving operational efficiencies, and aligning with regional and global market trends, industry players can confidently steer the future of TIPS interventions toward enhanced clinical outcomes and sustained market growth.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of liver diseases such as cirrhosis and portal hypertension
    • 5.1.1.2. Increasing adoption of minimally invasive surgical procedures due to faster recovery times
  • 5.1.2. Restraints
    • 5.1.2.1. Safety concerns and potential complications associated with intrahepatic portosystemic shunt procedures
  • 5.1.3. Opportunities
    • 5.1.3.1. Developing personalized TIPS treatment plans leveraging artificial intelligence for better patient outcomes
    • 5.1.3.2. Capitalizing on technological advancements in materials to enhance TIPS device efficacy and safety
  • 5.1.4. Challenges
    • 5.1.4.1. Insufficient insurance coverage and reimbursement issues related to TIPS procedures
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type: Rising need for accessory devices for minimally invasive surgical procedures
  • 5.2.2. Application: Increasing necessity for TIPS procedure for curing portal hypertension
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Transjugular Intrahepatic Portosystemic Shunt Market, by Product Type

• 6.1. Introduction
• 6.2. Accessory Devices
  • 6.2.1. Balloon Expanders
  • 6.2.2. Catheters
  • 6.2.3. Guiding Wires
• 6.3. Stents
  • 6.3.1. Bare Metal Stents
  • 6.3.2. Drug-Eluting Stents
  • 6.3.3. Sectional Stents

7. Transjugular Intrahepatic Portosystemic Shunt Market, by Procedure Type

• 7.1. Introduction
• 7.2. Elective Shunts
• 7.3. Emergency Shunts

8. Transjugular Intrahepatic Portosystemic Shunt Market, by Material Type

• 8.1. Introduction
• 8.2. Metallic Stents
• 8.3. Polymers

9. Transjugular Intrahepatic Portosystemic Shunt Market, by Application

• 9.1. Introduction
• 9.2. Budd-Chiari Syndrome
• 9.3. Hepatitis C
• 9.4. Liver Cirrhosis
• 9.5. Portal Hypertension

10. Transjugular Intrahepatic Portosystemic Shunt Market, by End-User

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Hospitals
• 10.4. Research Institutes
• 10.5. Specialty Clinics

11. Americas Transjugular Intrahepatic Portosystemic Shunt Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Transjugular Intrahepatic Portosystemic Shunt Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Transjugular Intrahepatic Portosystemic Shunt Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2024
• 14.2. FPNV Positioning Matrix, 2024
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Argon Medical enhances TIPS procedure with innovative liver management devices
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AngioDynamics Inc.
• 2. Argon Medical Devices, Inc.
• 3. Becton, Dickinson and Company
• 4. Boston Scientific Corporation
• 5. Cook Group Incorporated
• 6. Medtronic
• 7. Merit Medical Systems, Inc.
• 8. Siemens Healthcare Limited
• 9. Sirtex Medical Inc.
• 10. Terumo Medical Corporation
• 11. W. L. Gore & Associates, Inc.